SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-055606
Filing Date
2008-03-13
Accepted
2008-03-13 16:56:47
Documents
7
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1014465
2 SUBSIDIARIES OF REGISTRANT dex211.htm EX-21.1 1652
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 7432
4 RULE 13A-14(A) CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 9658
5 RULE 13A-14(A) CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 9702
6 SECTION 1350 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex321.htm EX-32.1 4056
7 SECTION 1350 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex322.htm EX-32.2 4230
  Complete submission text file 0001193125-08-055606.txt   1052636
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19825 | Film No.: 08686714
SIC: 2834 Pharmaceutical Preparations